HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Duane, W. C. Articles by Ho, S. B. Search for Related Content PubMed PubMed Citation Articles by Duane, W. C. Articles by Ho, S. B. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 41, 1384-1389, September 2000
Copyright © 2000 by Lipid Research, Inc.

Original Article

Diminished gene expression of ileal apical sodium bile acid transporter explains impaired absorption of bile acid in patients with hypertriglyceridemia

Correspondence to: William C. Duane

Patients with type IV hyperlipoproteinemia, particularly those with familial hypertriglyceridemia (FHT), have impaired absorption of bile acid, a defect that may contribute to the hypertriglyceridemia (J. Lipid Res. 1995. 36: 96;–107). To determine whether this absorption defect is a result of abnormal expression of the ileal apical sodium bile acid transporter (ASBT) gene, we biopsied the terminal ileum at colonoscopy in 28 subjects, 13 with hypertriglyceridemia and 15 control subjects. Of the 13 hypertriglyceridemic subjects, 10 had lipid profiles compatible with FHT (elevated very low density lipoprotein [VLDL] triglycerides with normal LDL cholesterol). ASBT mRNA levels were measured in these biopsies by RNase protection assay, using glyceraldehyde dehydrogenase mRNA as a reference. ASBT protein was quantitated by Western blotting with an antibody to the carboxy-terminal 20 amino acids of the protein. The mean ± SEM ASBT mRNA level in the control group was 205.7 ± 19.9 (arbitrary units) compared with 138.7 ± 19.1 for all 13 hypertriglyceridemics (P = 0.03) and 141.7 ± 20.8 in the 10 FHT patients (P = 0.05). Commensurate with these mRNA levels, the mean ASBT protein level in the control group was 126.2 ± 22.6 versus 58.8 ± 13.8 in hypertriglyceridemics (P = 0.02) and 61.8 ± 15.2 in the FHT patients (P = 0.05).

We conclude that impaired absorption of bile acid in type IV hypertriglyceridemia results from diminished expression of the ASBT gene in terminal ileum.—Duane, W. C., L. A. Hartich, A. E. Bartman, and S. B. Ho. Diminished gene expression of ileal apical sodium bile acid transporter explains impaired absorption of bile acid in patients with hypertriglyceridemia. J. Lipid Res. 2000. 41: 1384;–1389.

Supplementary key words: bile acids and salts, cholesterol, triglycerides, atherosclerosis, cholelithiasis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. C. Wertheim, M. E. Martinez, E. L. Ashbeck, D. J. Roe, E. T. Jacobs, D. S. Alberts, and P. A. Thompson Physical Activity as a Determinant of Fecal Bile Acid Levels Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1591 - 1598. [Abstract] [Full Text] [PDF]

				O. Renner, S. Harsch, A. Strohmeyer, S. Schimmel, and E. F. Stange Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease J. Lipid Res., September 1, 2008; 49(9): 2045 - 2054. [Abstract] [Full Text] [PDF]

				I. J. A. M. Jonkers, A. H. M. Smelt, H. M. G. Princen, F. Kuipers, J. A. Romijn, R. Boverhof, A. A. M. Masclee, and F. Stellaard Fish Oil Increases Bile Acid Synthesis in Male Patients with Hypertriglyceridemia J. Nutr., April 1, 2006; 136(4): 987 - 991. [Abstract] [Full Text] [PDF]

				B. G. Bhat, S. R. Rapp, J. A. Beaudry, N. Napawan, D. N. Butteiger, K. A. Hall, C. L. Null, Y. Luo, and B. T. Keller Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435 J. Lipid Res., September 1, 2003; 44(9): 1614 - 1621. [Abstract] [Full Text] [PDF]

				A. Cachefo, P. Boucher, E. Dusserre, P. Bouletreau, M. Beylot, and C. Chambrier Stimulation of cholesterol synthesis and hepatic lipogenesis in patients with severe malabsorption J. Lipid Res., July 1, 2003; 44(7): 1349 - 1354. [Abstract] [Full Text] [PDF]

				A. D. Attie, R. M. Krauss, M. P. Gray-Keller, A. Brownlie, M. Miyazaki, J. J. Kastelein, A. J. Lusis, A. F. H. Stalenhoef, J. P. Stoehr, M. R. Hayden, et al. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia J. Lipid Res., November 1, 2002; 43(11): 1899 - 1907. [Abstract] [Full Text] [PDF]

				K. L. West, T. Ramjiganesh, S. Roy, B. T. Keller, and M. L. Fernandez 1-[4-[4[(4R,5R)-3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]butyl]-4-aza-1-azoniabicyclo[2.2.2]octane Methanesulfonate (SC-435), an Ileal Apical Sodium-Codependent Bile Acid Transporter Inhibitor Alters Hepatic Cholesterol Metabolism and Lowers Plasma Low-Density Lipoprotein-Cholesterol Concentrations in Guinea Pigs J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 293 - 299. [Abstract] [Full Text] [PDF]

				D. Jung, M. Fried, and G. A. Kullak-Ublick Human Apical Sodium-dependent Bile Salt Transporter Gene (SLC10A2) Is Regulated by the Peroxisome Proliferator-activated Receptor alpha J. Biol. Chem., August 16, 2002; 277(34): 30559 - 30566. [Abstract] [Full Text] [PDF]

				M. W. Love, A. L. Craddock, B. Angelin, J. D. Brunzell, W. C. Duane, and P. A. Dawson Analysis of the Ileal Bile Acid Transporter Gene, SLC10A2, in Subjects With Familial Hypertriglyceridemia Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 2039 - 2045. [Abstract] [Full Text] [PDF]

				R. A. Davis and T. Y. Hui 2000 George Lyman Duff Memorial Lecture : Atherosclerosis Is a Liver Disease of the Heart Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 887 - 898. [Abstract] [Full Text] [PDF]

				J. H. Miyake, X.-D. T. Doung, W. Strauss, G. L. Moore, L. W. Castellani, L. K. Curtiss, J. M. Taylor, and R. A. Davis Increased Production of Apolipoprotein B-containing Lipoproteins in the Absence of Hyperlipidemia in Transgenic Mice Expressing Cholesterol 7alpha -Hydroxylase J. Biol. Chem., June 22, 2001; 276(26): 23304 - 23311. [Abstract] [Full Text] [PDF]

				I. Zaghini, J.-F. Landrier, J. Grober, S. Krief, S. A. Jones, M.-C. Monnot, I. Lefrere, M. A. Watson, J. L. Collins, H. Fujii, et al. Sterol Regulatory Element-binding Protein-1c Is Responsible for Cholesterol Regulation of Ileal Bile Acid-binding Protein Gene in Vivo. POSSIBLE INVOLVEMENT OF LIVER-X-RECEPTOR J. Biol. Chem., January 4, 2002; 277(2): 1324 - 1331. [Abstract] [Full Text] [PDF]